Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General PopulationHighlights
作者： Panagiotis Antiochos , Pedro Marques-Vidal , Julien Virzi , Sabrina Pagano , Nathalie Satta
DOI: 10.1161/ATVBAHA.117.309602
关键词:
摘要: Objective—We aimed to determine whether autoantibodies against apoA-1 (apolipoprotein A-1; anti-apoA-1 IgG) predict incident coronary artery disease (CAD), defined as adjudicated myocardia...
highwire.org参考文章(40)
H. W. L. Ziegler-Heitbrock, Molecular Mechanism in Tolerance to Lipopolysaccharide Journal of Inflammation. ,vol. 45, pp. 13- 26 ,(1995)
Tricia D. LeVan, John W. Bloom, Thomas J. Bailey, Christopher L. Karp, Marilyn Halonen, Fernando D. Martinez, Donata Vercelli, A Common Single Nucleotide Polymorphism in the CD14 Promoter Decreases the Affinity of Sp Protein Binding and Enhances Transcriptional Activity The Journal of Immunology. ,vol. 167, pp. 5838- 5844 ,(2001) , 10.4049/JIMMUNOL.167.10.5838
Ashham Mansur, Benjamin Liese, Maximilian Steinau, Michael Ghadimi, Ingo Bergmann, Mladen Tzvetkov, Aron Frederik Popov, Tim Beissbarth, Martin Bauer, José Hinz, The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study PLOS ONE. ,vol. 10, pp. e0127761- ,(2015) , 10.1371/JOURNAL.PONE.0127761
Sabrina Pagano, Hubert Gaertner, Fabrice Cerini, Tiphaine Mannic, Nathalie Satta, Priscila Camillo Teixeira, Paul Cutler, François Mach, Nicolas Vuilleumier, Oliver Hartley, The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0132780
S. Pagano, N. Satta, D. Werling, V. Offord, P. de Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard, N. Vuilleumier, Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine. ,vol. 272, pp. 344- 357 ,(2012) , 10.1111/J.1365-2796.2012.02530.X
J. Delgado Alves, P. R. J. Ames, S. Donohue, L. Stanyer, J. Noorouz-Zadeh, C. Ravirajan, D. A. Isenberg, Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis & Rheumatism. ,vol. 46, pp. 2686- 2694 ,(2002) , 10.1002/ART.10542
Suganya Viriyakosol, Grant E. O’Keefe, Robert S. Munford, Patricia A. Thompson, Richard L. Kitchens, Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins Journal of Clinical Investigation. ,vol. 108, pp. 485- 493 ,(2001) , 10.1172/JCI13139
Espen Røysamb, Evalill Karevold, Tilmann von Soest, Kristin Gustavson, None, Attrition and generalizability in longitudinal studies: findings from a 15-year population-based study and a Monte Carlo simulation study BMC Public Health. ,vol. 12, pp. 918- 918 ,(2012) , 10.1186/1471-2458-12-918
Nicolas Vuilleumier, Sylvette Bas, Sabrina Pagano, Fabrizio Montecucco, Pierre-André Guerne, Axel Finckh, Christian Lovis, François Mach, Denis Hochstrasser, Pascale Roux-Lombard, Cem Gabay, Anti–apolipoprotein A‐1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis Arthritis & Rheumatism. ,vol. 62, pp. 2640- 2650 ,(2010) , 10.1002/ART.27546
Hubertus PA Jersmann, Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunology and Cell Biology. ,vol. 83, pp. 462- 467 ,(2005) , 10.1111/J.1440-1711.2005.01370.X